Neurogene
NGNE
34 hedge funds and large institutions have $102M invested in Neurogene in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 7 closing their positions.
275% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 4
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
3% less funds holding
Funds holding: 35 → 34 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
27% less capital invested
Capital invested by funds: $139M → $102M (-$36.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Nexthera Capital
New York
|
+$3.96M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.34M |
| 3 |
RA
Royce & Associates
New York
|
+$687K |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$459K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$397K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$11.5M |
| 2 |
PA
Perceptive Advisors
New York
|
-$526K |
| 3 |
Morgan Stanley
New York
|
-$402K |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$220K |
| 5 |
AA
ALPS Advisors
Denver,
Colorado
|
-$171K |
NGNE Hedge Fund Activity: Q2 2016 in Review
34 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q2 2016, worth a combined $102M — down 27% from $139M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of NGNE and 6 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 15 added.
The largest buyer was Nexthera Capital, opening a new position worth an estimated $3.96M. The largest seller was Visium Asset Management, exiting entirely with an estimated $11.5M sold.
- 34 institutional investors held Neurogene (NGNE) as of Q2 2016, down from 35 in Q1 2016.
- Funds reported $102M of Neurogene stock for Q2 2016, down 27% quarter-over-quarter.
- 6 funds opened new Neurogene positions in Q2 2016 and 7 closed out, a net change of -1 holder.
- The largest Neurogene buyer in Q2 2016 was Nexthera Capital, an estimated $3.96M added.
- The largest Neurogene seller in Q2 2016 was Visium Asset Management, an estimated $11.5M sold.
Based on aggregated 13F filings for Q2 2016.